• News
  • Video
  • Prices
  • Research
  • Events
  • Data & Indices
  • More
  • Sponsored
    Sign In
    Sign Up
Loading chart...


About
  • About Us
  • Masthead
  • Careers
  • Blog
  • Investor Relations
Contact
  • Contact Us
  • Accessibility
  • Advertise
  • Media Kit
  • Sitemap
  • System status
Newsletters
  • CoinDesk Headlines
  • Crypto Daybook Americas
  • State of Crypto
  • Crypto for Advisors
  • Crypto Long & Short
News
  • Markets
  • Finance
  • Tech
  • Policy
  • Focus
Videos
  • CoinDesk Daily
  • Editor's Picks
  • Shorts
  • Spotlight
Podcasts
  • CoinDesk Podcast Network
  • Markets Outlook
  • Gen C
Cryptocurrencies
  • Latest crypto prices
  • Trending
  • Bitcoin (BTC)
  • Ethereum (ETH)
  • Hyperliquid (HYPE)
  • XRP
  • Solana (SOL)
Data & Indices
  • Market Data
  • Index Offering
  • API
  • Research Insights
  • Documentation and Governance
Events
  • CoinDesk: Policy & Regulation
  • Webinars
Sponsored
  • Thought Leadership
  • Press Releases
  • Advertise with CoinDesk
Research
  • Research Hub
  • Exchange Benchmark

EthicsPrivacyTerms of UseCookie SettingsDo Not Sell My InfoBug Bounty Program
X icon
© 2026 CoinDesk, Inc.

Disclosure & Polices: CoinDesk is an award-winning media outlet that covers the cryptocurrency industry. Its journalists abide by a strict set of editorial policies. CoinDesk has adopted a set of principles aimed at ensuring the integrity, editorial independence and freedom from bias of its publications. CoinDesk is part of Bullish (NYSE:BLSH), an institutionally focused global digital asset platform that provides market infrastructure and information services. Bullish owns and invests in digital asset businesses and digital assets and CoinDesk employees, including journalists, may receive Bullish equity-based compensation.

CD20$2,262.16CD20 up 5.61 percent5.61%BTC$81,304.02BTC up 5.50 percent5.50%ETH$2,512.30ETH up 5.54 percent5.54%XRP$1.45XRP up 7.97 percent7.97%SOL$104.01SOL up 4.46 percent4.46%
Prices > CRL
CRLCRL
$293.35Up 0.54 percent, +$1.590.54%($1.59)
As of today at 4:00 PM ET

Key Stats

Market Cap$13.479B
Volume (24h)571,848
Day's Range$285.90-$297.56
52-Week Range$144.26-$303.31
PE Ratio--
EPS-0.03
Net Income (FY)$-142.16M
Revenue (FY)$4.02B

About Charles River Laboratories International, Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.

Website
criver.com
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Full-time Employees
19,700
Headquarters
WILMINGTON
IPO Date
Jun 23, 2000
Loading chart...
24 hours5 days1 monthYTD1 yearAll time
Up 0.54 percent0.54%
Up 0.63 percent0.63%
Up 26.17 percent26.17%
Up 45.24 percent45.24%
Up 81.92 percent81.92%
Up 823.94 percent823.94%

Similar Stocks

S
S&P 500 ETFSPY
$773.17
Up 1.05 percent1.05%($8.01)
BullishBLSH
$35.61
Up 9.10 percent9.10%($2.97)
Coinbase Global IncCOIN
$191.67
Up 9.55 percent9.55%($16.71)
Circle Internet GroupCRCL
$102.60
Up 15.75 percent15.75%($13.96)

Latest CRL News

Global Pathology Services Market to Reach $307.9 Billion by 2030, Driven by Rising Cancer Incidence and AI-Enabled Diagnostic Innovation
3 days agoNeutral
(opens in a new tab)

Global Pathology Services Market to Reach $307.9 Billion by 2030, Driven by Rising Cancer Incidence and AI-Enabled Diagnostic Innovation

3 days agoNeutral(opens in a new tab)

Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?

7 days agoPositive(opens in a new tab)

Animal Testing and Non-Animal Alternative Testing Market Outlook 2025-2035 - Featuring Profiles of Charles River Laboratories, Labcorp, and Eurofins Scientific

8 days agoPositive(opens in a new tab)

Large Molecule Bioanalytical Testing Services Global Market Report 2026-2035 | Identify High-Growth Opportunities and Develop Informed Commercial Strategies

9 days agoPositive(opens in a new tab)

State of the Life Sciences Industry to Be Reviewed in BCC Research's 2026 Second Quarter Outlook, Spotlighting AI-Driven Discovery, Precision Oncology, and Connected Health Adoption

Jul 15, 2026, 6:46 a.m. ETPositive(opens in a new tab)

Global Clinical Trials Market to Reach $176.32 Billion by 2030 as AI and Decentralized Research Accelerate Growth

Jun 18, 2026, 1:00 p.m. ETPositive(opens in a new tab)

Global Cell and Gene Therapy CDMO Market Anticipating Remarkable Growth at a CAGR of ~24% by 2034 | DelveInsight